Stephen J. DiPalma
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Stephen J. DiPalma
Stephen J. DiPalma is recorded as CFO at Spero Therapeutics, Inc. (SPRO). Spero Therapeutics, Inc. reported in an 8-K filed June 14, 2023 that Stephen J. DiPalma was appointed Interim Chief Financial Officer and Treasurer, effective August 1, 2023.
“the Board appointed Stephen J. DiPalma to be the Company's Interim Chief Financial Officer and Treasurer to succeed Mr. Shukla, effective as of the Transition Date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-08-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Spero Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Esther Rajavelu CEO, CFO, Board Member
- Ankit Mahadevia, M.D. Chairman
- Frank E. Thomas Chairman
- Frank Thomas Chairman
- Christina Larkin COO
- Tim Keutzer COO
- Timothy Keutzer COO
- Satyavrat Shukla Chief Accounting Officer
- Cynthia Smith Board Member
- John C. Pottage Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.